Top Back to top

Retrospective analysis on the outcome of autologous and allogeneic stem cell transplantation in children and adolescents with non-anaplastic peripheral T-cell lymphoma

Paediatric Diseases Working Party (PDWP)
Study number:
 
Type of transplant:
 
Diseases:
Non-Hodgkin’s Lymphoma (NHL)
Short title:
 
Study status:
Closed
Deadline for data collection:
 
Study design:
 
Primary objective:
The primary end points are: Disease-free and overall survival
Secondary end points are: Incidence of relapse, non-relapse mortality; identification of parameters influencing the outcome of stem cell transplantation in pediatric non-anaplastic PTCL
Key inclusion criteria:
- Diagnosis of non-anaplastic peripheral T-cell lymphoma (PTCL) according to the WHO-classification (Campo, Blood 2011), i.e. except of ALK-positive and -negative anaplastic large cell lymphoma (ALCL)
- Age at primary diagnosis of non-anaplastic PTCL < 18 years
- Diagnosis after 1995
- Allogeneic and/or autologous stem cell transplantation
Country:
Germany
Principal investigator:
Olga Moser
Principal investigator email:
 
EBMT Study coordinator:
Arnaud Dalissier

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org